It is a pharma private limited company based in Himatnagar, Gujarat, India, established in 2020.
2020 | Himatnagar, Gujarat, India | ActiveCelaxis Bioscience Private Limited, a active private limited company, was established on 23 August 2020 in Himatnagar, Gujarat, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24100GJ2020PTC115766. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹3.00 Cr.
Its leadership includes Ramesh Kalawadia Makanbhai (Director), Chetan Satyendra Majmudar (Director), Jevil Dineshbhai Patel (Director). It holds ₹19.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 11, Shiv Bunglows, Nr. Gayatri Mandir, Mahavir Nagar, Kanknol, Himatnagar,, Himatnagar, Gujarat, 383001.
U24100GJ2020PTC115766
115766
23 August 2020
₹3.00 Cr
₹3.00 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Celaxis Bioscience Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ramesh Kalawadia Makanbhai | Director | 01 Jun 2025 | Current |
| Chetan Satyendra Majmudar | Director | 01 Jun 2025 | Current |
| Jevil Dineshbhai Patel | Director | 23 Aug 2020 | Current |
| Darshan Mahendra Mahendra | Director | 23 Aug 2020 | Current |
| Dineshkumar Amichandbhai Patel | Director | 23 Aug 2020 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Celaxis Bioscience Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 12933.33% increase in profit. The company's net worth Soared by an impressive increase of 6568.61%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
In 2021, Celaxis Bioscience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹190,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Dec 2021 | Others | ₹9.50 Cr | Open |
| 15 Dec 2021 | Others | ₹9.50 Cr | Open |
Explore comprehensive loan charge details -
Celaxis Bioscience has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Celaxis Bioscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Celaxis Bioscience's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Ramesh Kalawadia Makanbhai was appointed as a Director was appointed as a Director on 01 Jun 2025 & has been associated with this company since 5 months 29 days . was recorded as a recent event.
The activity Chetan Satyendra Majmudar was appointed as a Director was appointed as a Director on 01 Jun 2025 & has been associated with this company since 5 months 29 days . was completed.
Celaxis Bioscience Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Celaxis Bioscience Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was recorded as a recent event.
A charge with Others amounted to Rs. 9.50 Cr with Charge ID 100513541 was registered on 15 Dec 2021. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 9.50 Cr with Charge ID 100513534 was registered on 15 Dec 2021. was completed.
The CIN of Celaxis Bioscience Private Limited is U24100GJ2020PTC115766.
Celaxis Bioscience Private Limited is headquartered at 11, Shiv Bunglows, Nr. Gayatri Mandir, Mahavir Nagar, Kanknol, Himatnagar,, Himatnagar, Gujarat, 383001.
Celaxis Bioscience Private Limited was incorporated on 23 August 2020.
The current directors of Celaxis Bioscience Private Limited are
The primary industry of Celaxis Bioscience Private Limited is Pharma.
Celaxis Bioscience Private Limited is unlisted.
The authorized capital of Celaxis Bioscience Private Limited is ₹3.00 Cr, and the paid-up capital is ₹3.00 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX